Last reviewed: June 29, 2026
Last updated: June 29, 2026
Written by:
Jay Hastings,
CEO of PlexusDx
Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.
Medically reviewed by:
Jayden Lee, PharmD, EMBA
Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.
This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.
Wegovy pens are pre-filled injection devices that deliver semaglutide, a GLP-1 receptor agonist that slows stomach emptying and reduces hunger signals in the brain. Each pen contains multiple doses designed to be administered weekly over a 16-week initiation phase, starting at 0.25 mg and increasing to a maintenance dose of 2.4 mg. PlexusDx offers compounded semaglutide as a more affordable alternative, with pricing that stays flat at $149/mo regardless of your current dose level.
Understanding Wegovy Pen Dose Structure and Delivery
A standard Wegovy pen contains enough semaglutide for four weekly injections at the same dose strength. The brand-name product comes in four separate pen designs: 0.25 mg, 0.5 mg, 1 mg, and 2.4 mg concentrations. Patients move through these pens sequentially during the 16-week titration schedule, meaning they use one complete pen before advancing to the next strength. This design requires patients to purchase or refill multiple pens over several months to complete the initiation protocol.
Each injection uses a thin needle and takes only seconds to administer. The graduated approach allows the body to adapt gradually to semaglutide, reducing gastrointestinal side effects during the first month of treatment. Once a patient reaches their target maintenance dose—typically 2.4 mg weekly—they may stay on that dose indefinitely or have it adjusted based on individual response and tolerability.
Why Wegovy's Multi-Pen System Affects Your Budget
The brand-name Wegovy structure means patients pay for each pen separately, creating cumulative costs during the titration phase. A single Wegovy pen costs between $935 and $1,600 without insurance, depending on your location and pharmacy. Since patients transition through four different pen strengths over 16 weeks, the total out-of-pocket cost during initiation can exceed $3,700 to $6,400 before reaching maintenance dosing.
This tiered purchasing model creates financial uncertainty for patients who want to know their total cost upfront. Many insurance plans cover Wegovy only after specific criteria are met, leaving self-pay patients to absorb full manufacturer pricing. PlexusDx eliminates this complexity by charging a flat $149/mo rate for compounded semaglutide injections, regardless of whether your dose is 0.25 mg or 2.4 mg, ensuring your price remains stable as your dose increases.
How PlexusDx Compounded Semaglutide Simplifies Dosing
PlexusDx partners with licensed 503A compounding pharmacies to prepare custom semaglutide injections tailored to each patient's current dose. Rather than purchasing pre-filled pens in fixed strengths, PlexusDx compounds syringes or pens in the exact dose your provider recommends, whether that's 0.25 mg, 1.5 mg, or 2.0 mg. This flexibility means you are never forced to buy an entire pen of a dose you've already outgrown, eliminating waste and reducing unnecessary expense.
Compounded medications from licensed 503A pharmacies undergo the same sterility and potency testing as brand-name injectables, ensuring safety and efficacy. PlexusDx delivers medication directly to your home with no membership fees or insurance requirements, and your HSA or FSA account can be used to pay for treatment. The flat monthly pricing model means your budget stays predictable whether you are in week two of treatment or maintaining your dose six months later.
Genetic Testing to Optimize Your Semaglutide Response
Not every patient responds equally to the same semaglutide dose, and genetic variations influence how your body processes GLP-1 receptor signaling. The PlexusDx Precision Peptide Genetic Test analyzes key variants in the GLP1R, GIPR, FTO, and MC4R genes that affect appetite regulation and weight loss response. This peptide-pathway genetic test maps 14 biological pathways and 49 peptides, providing insights into whether you may require a higher maintenance dose or may achieve results at a lower threshold.
Understanding your genetic predispositions allows your PlexusDx provider to personalize your dosing strategy from the start, potentially reducing side effects and accelerating therapeutic benefit. The genetic test is available as a $99 add-on after your first month of treatment, giving you a complete picture of your body's unique peptide biology. Armed with this data, your provider can adjust your semaglutide dose with greater precision, supporting more predictable outcomes and higher patient satisfaction.
How Your Genetics Influence GLP-1 Response
Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.
Access Personalized GLP-1 Care Through PlexusDx
PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.
Frequently Asked Questions
How many injections come in a single Wegovy pen?
Each Wegovy pen contains enough medication for four weekly injections at one dose strength. Patients progress through multiple pens (0.25 mg, 0.5 mg, 1 mg, and 2.4 mg) over 16 weeks during the initiation phase. PlexusDx compounded semaglutide is dosed individually by your provider, so you only receive the exact amount prescribed each month.
Why does Wegovy cost so much compared to PlexusDx semaglutide?
Brand-name Wegovy requires purchasing four separate pen types during titration, with each pen costing $935–$1,600, totaling over $3,700 during initiation. PlexusDx charges a flat $149/mo for compounded semaglutide from licensed 503A pharmacies, with no per-dose increase, making it significantly more affordable while maintaining the same safety and efficacy standards.
Can I use HSA or FSA funds to pay for PlexusDx semaglutide?
Yes, PlexusDx compounded semaglutide injections are eligible for both HSA and FSA payments. No insurance is required to use PlexusDx, and there are no membership or enrollment fees, making it accessible for patients seeking affordable, personalized GLP-1 therapy across all 50 states.
Is compounded semaglutide as safe as brand-name Wegovy?
PlexusDx compounded semaglutide is prepared by licensed 503A compounding pharmacies, which follow strict sterility, potency, and stability standards equivalent to FDA-approved manufacturers. Compounding is not an FDA-approval pathway, but 503A compounders are federally regulated and frequently used by hospitals and clinics. Always obtain your medication from a reputable compounding source and work with a qualified healthcare provider.
How can genetic testing help optimize my semaglutide dose?
The PlexusDx Precision Peptide Genetic Test identifies variations in your GLP1R, GIPR, FTO, and MC4R genes that influence appetite regulation and weight loss response. These insights help your provider personalize your starting and maintenance doses, potentially improving outcomes and reducing trial-and-error dosing. The test costs $99 and is available as an add-on after your first month of treatment.
Related Reading
Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.
Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.
Medical and Editorial Standards
Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.
Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.
Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.
Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.
Share:
Navigating Weight Loss After Pancreatitis: Can You Take Ozempic?
Navigating Medications: Can I Take Ibuprofen While on Ozempic?